• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CHM
Click for more information
0.00% 0.9¢

CHIMERIC THERAPEUTICS LIMITED - Charts / Financials

Market Cap $12.51M  ! watchlist Created with Sketch. Add to my watchlist

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company.... Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company. The Company is focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its pipeline includes CHM 1101 and CHM 2101. Its CHM 1101 (CLTX CAR-T) is a CAR-T therapy developed for the treatment of patients with solid tumors. CHM-1101 is being studied in a Phase 1B clinical trial in recurrent/ progressive glioblastoma. CHM 2101 is a third generation CDH17 CAR T, which is in preclinical development with a planned Phase I clinical trial in neuroendocrine tumors, colorectal, pancreatic and gastric cancer. Its pipeline also includes the CORE-NK platform, a clinically validated, off-the-shelf natural killer (NK) cell therapy platform to their portfolio (CHM 0201). The Company is also focused on the development of NK and CAR NK assets with plans for Phase 1B clinical trials in solid tumors and blood cancers.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 12.55pm 22/11/2024 (20 minute delay) ?
Day
Open 0.9¢   Day High 0.9¢   Day Low 0.9¢
Daily Volume 85510
Bids   Sellers
Number Price Volume   Number Price Volume
19 0.9¢ 5013131   6 1.0¢ 1067490

Directors & Senior Management

Mr. Paul Hopper Executive Chairman of the Board, Founder
Mr. Phillip Hains Chief Financial Officer, Joint Company Secretary, Director
Dr. Rebecca Mcqualter Chief Operating Officer
Dr. Eliot Bourk Chief Business Officer
Dr. Jason B. Litten Chief Medical Officer
Mr. Nathan Jong Joint Company Secretary
Dr. Lesley Russell Non-Executive Director
Mr. Eric M. Sullivan Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
0.9¢ 		Change
0.000(0.00%) 		Mkt cap ! $12.51M
Open High Low Value Volume
0.9¢ 0.9¢ 0.9¢ $770 85.51K

Buyers (Bids)

No. Vol. Price($)
19 5013131 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 1067490 6
Last trade - 13.21pm 22/11/2024 (20 minute delay) ?
Last
1.0¢ 		  Change
0.000 ( 11.1 %)
Open High Low Volume
1.0¢ 1.0¢ 1.0¢ 415000
Last updated 12.55pm 22/11/2024 ?

Top Stories

Sales growth pushes Lovisa's fortunes (and shares) upwards

Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and on a good day for the consumer discretionary sector
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.